Related Experiment Video
Updated: Jan 22, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Proton Pump Inhibitor Use and Risk of Dementia in the Veteran Population
Jenna Welu1, Justin Metzger1, Scott Bebensee1
1is a Pharmacy Resident, is Chief of Pharmacy, is a Home-Based Primary Care Clinical Pharmacy Specialist, is a Systems Redesigner, and is a Program Analyst, all at the Sioux Falls VA Health Care System in South Dakota. April Ahrendt is an Academic Assistant Professor at the University of South Dakota School of Health Sciences in Vermillion.
Abstract:
There was a statistically significant association between use of proton pump inhibitors and dementia diagnosis in a 11-year retrospective study of patients at the Sioux Falls Veteran Affairs Health Care System.
More Related Videos
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Dementia
The progression of dementia is generally gradual....
Conservation of Small Populations
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...

